1IXD | Antitumor Protein | date | Jun 19, 2002 |
---|---|---|---|
title | Solution Structure Of The Cap-Gly Domain From Human Cylindro Tomour-Suppressor Cyld | ||
authors | K.Saito, S.Koshiba, T.Kigawa, S.Yokoyama, Riken Structural Genomicsproteomics Initiative (Rsgi) | ||
compound | source | ||
Molecule: Cylindromatosis Tumour-Suppressor Cyld Chain: A Fragment: Cap-Gly Domain Synonym: Probable Ubiquitin Carboxyl-Terminal Hydrolase Cyl Ubiquitin Thiolesterase Cyld, Ubiquitin-Specific Processing Cyld, Deubiquitinating Enzyme Cyld, Hspc057; Ec: 3.1.2.15 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Fh04363 Expression_system_vector_type: Plasmid Expression_system_plasmid: P011213-03 Other_details: Cell-Free Protein Synthesis | ||
method | Solution NMR | ||
ligand | enzyme | Hydrolase E.C.3.1.2.15 BRENDA | |
Primary reference | The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma., Saito K, Kigawa T, Koshiba S, Sato K, Matsuo Y, Sakamoto A, Takagi T, Shirouzu M, Yabuki T, Nunokawa E, Seki E, Matsuda T, Aoki M, Miyata Y, Hirakawa N, Inoue M, Terada T, Nagase T, Kikuno R, Nakayama M, Ohara O, Tanaka A, Yokoyama S, Structure (Camb) 2004 Sep;12(9):1719-28. PMID:15341735 |
Data retrieval |
View 1IXD in 3D |
Visual 3D analysis of 1IXD |
Structure-derived information |
- Domain d1ixda_, region A [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1IXD |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |